Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCoya Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Coya Therapeutics, Inc.

$4.97Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $243.75K. Net result −$6.64M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $243.75K. Running result $243.75K. Revenue: $243.75K.
  • Cost of revenue: $0. Running result $243.75K.
  • Gross profit: $243.75K. Running result $243.75K.
  • Research and development: −$5.03M. Running result −$4.79M.
  • In-process research and development: −$1.66K. Running result −$4.79M.
  • General and administrative: −$2.26M. Running result −$7.04M.
  • Depreciation: −$2.81K. Running result −$7.05M.
  • Other operating costs: −$2.81K. Running result −$7.05M.
  • Operating income: −$7.05M. Running result −$7.05M.
  • Other income: $408.73K. Running result −$6.64M.
  • Pre-tax loss: −$6.64M. Running result −$6.64M.
  • Income tax benefit: $0. Running result −$6.64M.
  • Net loss: −$6.64M. Running result −$6.64M.